Dr. Ali A M Hassoun, MD

Dr. Hassoun practices at Huntsville Hospital in Huntsville, Alabama, part of City of Huntsville, AL.

Dr. Hassoun's NPI, 1063404978, was assigned on August 17, 2005. Dr. Hassoun holds Alabama license 25943.

Dr. Hassoun's primary practice is Huntsville Hospital, at 101 Sivley Rd, Huntsville, AL 35801 in Madison County. The practice phone is (256) 265-1000.

Dr. Hassoun's primary practice is Huntsville Hospital in Huntsville, Alabama, part of City of Huntsville, AL. Dr. Hassoun is also affiliated with Crestwood Medical Center. The medical group on file is Alabama Infectious Disease Center. Dmand AI also links Dr. Hassoun to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hassoun practices, 7 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Hassoun's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Hassoun is licensed in Alabama.

CMS data shows 3,060 Medicare services from Dr. Hassoun across 5 procedure codes in 2024, for 522 Medicare patients. Medicare paid $208,421 for them.

CMS counts 522 Medicare patients who saw Dr. Hassoun in 2024. The largest group is 75 to 84, with 173 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hassoun's median patient age at 71, with 50% women.

In 2024, Dr. Hassoun wrote 1,747 Medicare Part D claims for 247 patients. 79% of them were for generic drugs. CMS names the drug for 1,631 of them, across 30 drugs with 11 or more claims each, at $1,153,063 in total drug cost. In 2023, CMS named 1,316 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Hassoun for performance year 2024, reported as part of a group. Dr. Hassoun accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 25 papers to Dr. Hassoun, published from 2012 to 2025. 2017 was the busiest year, with 3. The most frequent topics are Anti-Bacterial Agents, Aminoglycosides and Lipoglycopeptides. Dr. Hassoun has published most often in BMJ Case Rep. Dr. Hassoun's most frequent co-authors are Usha Yendrapalli, MD, Amir Azarbal, MD and Adam Matthew Bressler, MD.

CMS Open Payments shows 1,292 general payments to Dr. Hassoun from 36 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 58% of the total. Theravance Biopharma, Inc. paid the most, $120,336.